The University of Tennessee has been on the front lines of the COVID-19 pandemic, from the N95 mask technology to developing systems to quickly and safely screen vaccines, as used by Moderna and Pfizer. These contributions were recently recognized by AUTM’s Better World Project, which named the University of Tennessee Research Foundation (UTRF) as its 2020 Legend Award honoree and spotlighted its work on Gene Pool Innovations for its role in moving academic research from the lab to the marketplace.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce. Published in the Journal of Medicinal Chemistry, the research provides key insights for advancing drug design and drug repurposing efforts to treat COVID-19.
When the world is watching, and you’re working security at high-profile events during a pandemic, standard safety protocols aren’t enough. For team members of the Region 2 Radiological Assistance Program (RAP), attending the Presidential Inauguration in Washington, D.C., and Super Bowl 55 in Tampa, Florida, involved total focus to the mission and enhanced COVID-19 protocols.
East Tennessee Wellness Roundtable (ETWR) is happy to announce the kickoff of the 2021 Recognition Program. The purpose of the three-tier recognition program is to recognize employers who are pursuing opportunities to exemplify excellence in worksite wellness and consistently working to move the needle on worksite health. Recognition is available for worksites of any size.